Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 6/27/2025 | 3/28/2025 | 12/27/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | $7,697,650 | $7,503,865 |
| - Cash | $701,893 | $698,566 | $750,342 | $611,657 |
| + Debt | $28,494 | $28,160 | $40,431 | $44,445 |
| Enterprise Value | – | – | $6,987,739 | $6,936,653 |
| Revenue | $307,024 | $315,546 | $369,561 | $356,999 |
| % Growth | -2.7% | -14.6% | 3.5% | – |
| Gross Profit | $267,505 | $271,544 | $333,724 | $316,225 |
| % Margin | 87.1% | 86.1% | 90.3% | 88.6% |
| EBITDA | $60,380 | $71,490 | $144,677 | $111,248 |
| % Margin | 19.7% | 22.7% | 39.1% | 31.2% |
| Net Income | $49,332 | $46,071 | $91,793 | $67,822 |
| % Margin | 16.1% | 14.6% | 24.8% | 19% |
| EPS Diluted | 0.51 | 0.48 | 0.94 | 0.7 |
| % Growth | 6.3% | -48.9% | 34.3% | – |
| Operating Cash Flow | $122,831 | $67,691 | $174,897 | $106,779 |
| Capital Expenditures | -$21,837 | -$6,428 | -$6,897 | -$6,779 |
| Free Cash Flow | $100,994 | $61,263 | $168,000 | $100,000 |